{"entity":{"id":"epigenetic-marks","kind":"term","name":"Epigenetic marks and DNA methylation","aka":["epigenetics","DNA methylation","5-methylcytosine","5-hydroxymethylcytosine","5mC","5hmC","histone modification"],"tldr":"Chemical features of DNA and its packaging can influence how genes are used. Their location and cellular context matter; a mark does not have one universal effect.","summary":"DNA methylation changes a base’s chemical state without substituting the underlying sequence letter. Much human methylation analysis concerns 5-methylcytosine at CpG sites. Histone modifications affect DNA-associated proteins and are distinct from marks on DNA itself. Some regulatory states persist through division; epigenetic does not mean every mark is permanent or transmitted between generations. Promoter methylation can participate in reduced transcription, while patterns elsewhere need their own interpretation.","asOf":"2026-11-13","links":[{"label":"NHGRI: epigenomics","url":"https://www.genome.gov/about-genomics/fact-sheets/Epigenomics-Fact-Sheet"},{"label":"Human DNA methylomes at base resolution show widespread epigenomic differences.","url":"https://pubmed.ncbi.nlm.nih.gov/19829295/"},{"label":"A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands.","url":"https://pubmed.ncbi.nlm.nih.gov/1542678/"},{"label":"Oxidative bisulfite sequencing of 5-methylcytosine and 5-hydroxymethylcytosine.","url":"https://pubmed.ncbi.nlm.nih.gov/24008380/"}],"tags":[],"related":["epigenetic-reprogramming","methylation-profiling","methylation-arrays","gene-expression","histone-lactylation"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Standard bisulfite analysis changes unmodified cytosine but reads both 5-methylcytosine and 5-hydroxymethylcytosine as C. Oxidative bisulfite methods separate those features through additional chemistry. Ordinary amplified DNA sequence does not preserve this direct chemical measurement.","A methylation signal in mixed tissue is not a percentage of cancer cells with a silenced gene. Cell mixture, genomic location, conversion controls and method resolution matter. Association with low RNA does not establish causation or treatment sensitivity.","In an invented sequence example, AACGT can carry a methyl group on its C while the underlying base order remains AACGT. Replacing that C with T instead gives AATGT, a different underlying DNA sequence. Changing a chemical mark on a histone protein is different again. Keep that biological comparison separate from an assay that chemically converts bases: standard bisulfite treatment can change the readout without establishing that the original DNA carried a C-to-T variant. Read the conversion chemistry, locus and cell context before interpreting a methylation call."],"category":"Clinic basics"},"route":"/terms/epigenetic-marks/","neighbours":{"pathway":[{"id":"epigenetic-reprogramming","kind":"pathway","name":"Epigenetic reprogramming","route":"/pathways/epigenetic-reprogramming/"}],"technology":[{"id":"methylation-profiling","kind":"technology","name":"DNA methylation profiling","route":"/technologies/methylation-profiling/"}],"term":[{"id":"methylation-arrays","kind":"term","name":"DNA methylation arrays and beta values (450k, EPIC)","route":"/terms/methylation-arrays/"},{"id":"gene-expression","kind":"term","name":"Gene expression","route":"/terms/gene-expression/"},{"id":"histone-lactylation","kind":"term","name":"Histone lactylation","route":"/terms/histone-lactylation/"},{"id":"gene-regulatory-elements","kind":"term","name":"Promoters, enhancers and transcription factors","route":"/terms/gene-regulatory-elements/"}]}}